<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To find the best immunohistochemical marker for megakaryocytes in <z:mpath ids='MPATH_458'>normal</z:mpath> marrow, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e>), 57 marrow biopsy specimens were studied semiquantitatively with immunohistochemical methods using a panel of 7 antibodies </plain></SENT>
<SENT sid="1" pm="."><plain>The staining intensity was graded 0 to 3 for scoring 100 consecutive megakaryocytes in each stained section </plain></SENT>
<SENT sid="2" pm="."><plain>The final score for each stain was the sum of these 100 megakaryocytes individually multiplied by their corresponding grade </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> marrow (11 cases), the average scores for antivon Willebrand factor (vWF) and Ulex europaeus agglutinin-1 (UEA-1) were 177.1 and 195.1, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>The scores for the other 5 markers, including anti-platelet-derived growth factor-BB, 2 anti-transforming growth factor-beta 3, anti-CD61, and anti-CD79a ranged from 96.1 to 124.1 </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (27 cases), the scores were 200.8 (vWF), 152.6 (UEA-1), and 28.7 to 98.5 (others) </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> (19 cases), the scores were 220.5 (vWF), 179.2 (UAE-1), and 64.8 to 101.2 (others) </plain></SENT>
<SENT sid="7" pm="."><plain>These results show that vWF and UEA-1 are good immunohistochemical markers for megakaryocytes in <z:mpath ids='MPATH_458'>normal</z:mpath> marrow, and vWF is the best marker in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMPD</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>For routine practice, vWF is the most reliable marker for identifying atypical megakaryocytes, especially in the cases of <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e> and agnogenic <z:mpath ids='MPATH_173'>myeloid metaplasia</z:mpath> </plain></SENT>
</text></document>